These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oral routes for immunotherapy: clinical efficacy and kinetics of the allergen. Canonica GW, Passalacqua G, Mariani G, Motta C, Bartolomei M, Mistrello G, Falagiani P, Bagnasco M. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):56-64; discussion 64-7. PubMed ID: 9383892 [No Abstract] [Full Text] [Related]
11. Role of tolerance in the development of eosinophilic gastrointestinal diseases. Varshney P, Burks AW. Immunol Allergy Clin North Am; 2009 Feb; 29(1):179-87, xiii. PubMed ID: 19141353 [Abstract] [Full Text] [Related]
12. Oral immunotherapy: ready for prime time? Katz Y, Goldberg MR, Stein M, Levy M. J Allergy Clin Immunol; 2011 Jan; 127(1):289-90; author reply 291-2. PubMed ID: 21040954 [No Abstract] [Full Text] [Related]
14. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually. Panzner P, Petrás M, Sýkora T, Lesná I. Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908 [Abstract] [Full Text] [Related]
15. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy. Patriarca G, Nucera E, Roncallo C, Aruanno A, Lombardo C, Decinti M, Pascolini L, Milani M, Buonomo A, Schiavino D. J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349 [No Abstract] [Full Text] [Related]
16. Sublingual immunotherapy: from safety to mechanism of action. Marcucci F, Sensi L, Allocca G, Chiarello F, Palleri P, Ugolini E, Di Rienzo A, Castellani S, Incorvaia C, Di Cara G, Puccinelli P, Frati F. Eur Ann Allergy Clin Immunol; 2007 Mar; 39(3):101-3. PubMed ID: 17465282 [Abstract] [Full Text] [Related]